Salud

Adolescentes de 16 y 17 años podrán recibir refuerzos contra covid-19 en EE.UU.

Es una sola dosis para quienes hayan completado su esquema hace seis meses o más; en Costa Rica, refuerzo solo está avalado para mayores de 18 años

(FILES) In this file photo taken on September 13, 2021 an elerly patient receives the third dose of the Pfizer-BioNtech Covid-19 vaccine in Paris. - A booster shot of the anti-Covid-19 vaccine developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to trial data published by the makers on October 21, 2021. The clinical phase three trial with "10,000 participants 16 years of age and older" showed "a relative vaccine efficacy of 95.6 percent against disease during a period when Delta was the prevalent strain", the companies said in a statement. (Photo by THOMAS COEX / AFP)
(FILES) In this file photo taken on September 13, 2021 an elerly patient receives the third dose of the Pfizer-BioNtech Covid-19 vaccine in Paris. - A booster shot of the anti-Covid-19 vaccine developed by Pfizer/BioNTech is 95.6 percent effective against symptomatic infection, according to trial data published by the makers on October 21, 2021. The clinical phase three trial with "10,000 participants 16 years of age and older" showed "a relative vaccine efficacy of 95.6 percent against disease during a period when Delta was the prevalent strain", the companies said in a statement. (Photo by THOMAS COEX / AFP) THOMAS COEX
‌
‌

‌

‌
‌

‌

‌